KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Gsk (GSK) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Gsk (GSK) over the last 17 years, with Q4 2025 value amounting to $966.9 million.

  • Gsk's Profit After Tax fell 6841.27% to $966.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $8.3 billion, marking a year-over-year increase of 3446.74%. This contributed to the annual value of $8.3 billion for FY2025, which is 11985.91% up from last year.
  • According to the latest figures from Q4 2025, Gsk's Profit After Tax is $966.9 million, which was down 6841.27% from $2.9 billion recorded in Q3 2025.
  • Gsk's Profit After Tax's 5-year high stood at $4.3 billion during Q4 2022, with a 5-year trough of $84.5 million in Q3 2024.
  • Its 5-year average for Profit After Tax is $2.2 billion, with a median of $2.1 billion in 2021.
  • Its Profit After Tax has fluctuated over the past 5 years, first crashed by 9674.45% in 2024, then surged by 332475.32% in 2025.
  • Over the past 5 years, Gsk's Profit After Tax (Quarter) stood at $1.3 billion in 2021, then skyrocketed by 245.9% to $4.3 billion in 2022, then decreased by 3.37% to $4.2 billion in 2023, then fell by 26.94% to $3.1 billion in 2024, then crashed by 68.41% to $966.9 million in 2025.
  • Its Profit After Tax was $966.9 million in Q4 2025, compared to $2.9 billion in Q3 2025 and $2.2 billion in Q2 2025.